---
schema_version: "secwatch.filing_event.v1"
accession: "0000937556-26-000005"
form_type: "8-K"
ticker: "MASI"
cik: "0000937556"
company_name: "MASIMO CORP"
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T11:00:36.815701+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Masimo preliminary Q4 rev $411M (+12% YoY); FY25 rev $1,523M (+9%), non-GAAP EPS >$5.55

## Summary
- Q4 revenue ~$411M (~12% reported growth; 11% constant currency).
- Non-GAAP diluted EPS in Q4 >$1.54, including tariff impact.
- Full-year 2025 revenue ~$1,523M (+9% YoY); non-GAAP EPS >$5.55 (high end of guidance).
- Noninvasive tech board/instrument shipments: Q4 ~69k, FY ~270k.
- CEO reports record incremental contract value from new and expanded hospital agreements.

## SEC filing metadata
- accession: 0000937556-26-000005
- form_type: 8-K
- ticker: MASI
- cik: 0000937556
- company_name: MASIMO CORP
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/937556/000093755626000005/0000937556-26-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/937556/000093755626000005/masi-20260112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000937556-26-000005
- JSON: https://secwatch.observer/filing/0000937556-26-000005.json
- Plain text: https://secwatch.observer/filing/0000937556-26-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.